Literature DB >> 11840399

Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia.

Wen-Chin Chen1, Shi-Chuan Chang, Tsai-Hung Wu, Wu-Chang Yang, Der-Cherng Tarng.   

Abstract

Hypercalcemia occurs frequently after renal transplantation. Preexisting hyperparathyroidism is the most common cause of post-transplantation hypercalcemia. We describe a renal transplant recipient infected with Pneumocystis carinii pneumonia (PCP) who developed hypercalcemia, elevated 1,25-dihydroxyvitamin D, and suppressed parathyroid hormone levels. This phenomenon mimics the extrarenal production of 1,25-dihydroxyvitamin D by activated alveolar macrophages in granulomatous diseases with hypercalcemia. To the best of our knowledge, this is the first report of 1,25-dihydroxyvitamin D-mediated hypercalcemia caused by PCP in a renal transplant recipient. This entity should be included in the differential diagnosis for renal transplant recipients with hypercalcemia, especially in patients who develop lung infections. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11840399     DOI: 10.1053/ajkd.2002.30578

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  The Case | Hypercalcemia in a renal transplant recipient.

Authors:  Lisa Dubrofsky; Mark L Lipman; Sharon J Nessim
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

Review 2.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

3.  Hypercalcemia Heralding Pneumocystis jirovecii Pneumonia in an HIV-Seronegative Patient with Diffuse Cutaneous Systemic Sclerosis.

Authors:  Quentin Binet; Jacques Mairesse; Marie Vanthuyne; Jean-Christophe Marot; Grégoire Wieers
Journal:  Mycopathologia       Date:  2019-11-15       Impact factor: 2.574

4.  Metagenomic Next-Generation Sequencing in Diagnosis of a Case of Pneumocystis jirovecii Pneumonia in a Kidney Transplant Recipient and Literature Review.

Authors:  Jie Chen; Ting He; Xiujun Li; Xue Wang; Li Peng; Liang Ma
Journal:  Infect Drug Resist       Date:  2020-08-13       Impact factor: 4.003

5.  Pneumocystis jirovecii pneumonitis: cause of acute hypercalcaemia in chronic haemodialysis patient.

Authors:  Florian Garo; Cedric Aglae; Pedram Ahmadpoor; Olivier Moranne
Journal:  BMJ Case Rep       Date:  2020-01-26

6.  HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia.

Authors:  Sabiha Shahnaz; David Reich; Diana Arévalo-Valencia; Slavka Kucinska; Joanna Tulczynska; Jean Fleischman
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

7.  A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+.

Authors:  Anders Nordholm; Maria L Mace; Eva Gravesen; Klaus Olgaard; Ewa Lewin
Journal:  BMC Nephrol       Date:  2015-03-15       Impact factor: 2.388

8.  Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients.

Authors:  Jonathan Ling; Tara Anderson; Sanchia Warren; Geoffrey Kirkland; Matthew Jose; Richard Yu; Steven Yew; Samantha Mcfadyen; Alison Graver; William Johnson; Lisa Jeffs
Journal:  Clin Kidney J       Date:  2017-06-23

9.  Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.

Authors:  Amy A Yau; Samira S Farouk
Journal:  BMC Infect Dis       Date:  2019-08-22       Impact factor: 3.090

10.  Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.

Authors:  Aghilès Hamroun; Rémi Lenain; Linh Bui Nguyen; Paul Chamley; Séverine Loridant; Yann Neugebauer; Arnaud Lionet; Marie Frimat; Marc Hazzan
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.